My Recently Viewed Products

Amyloid beta A4 (CT, 1-42) Monoclonal Antibody (8G7)

Brand: Assay Designs Print Page
Description Size Catalog# Price Quantity  
Amyloid beta A4 (CT, 1-42) Monoclonal Antibody (8G7) 100 µg   905-804 $320.00
Background
The beta-amyloid peptide (beta A4), proteolytically released from the amyloid precursor protein (APP), provides the principal component of senile plaques in Alzheimer's disease. Cleavage of APP by alpha-secretase or alternatively by beta-secretase leads to generation and extracellular release of soluble APP peptides, S-APP-alpha and S-APP-beta, respectively, and the retention of corresponding membrane-anchored C-terminal fragments, C83 and C99. Subsequent processing of C83 by gamma-secretase yields P3 peptides. This is the major secretory pathway and is nonamyloidogenic. Alternatively, presenilin/ nicastrin-mediated gamma-secretase processing of C99 releases the amyloid beta proteins, amyloid-beta 40 (Abeta40) and amyloid-beta 42 (Abeta42), major components of amyloid plaques, and the cytotoxic C-terminal fragments, gamma-CTF(50), gamma-CTF(57) and gamma-CTF(59).

Table of Abbreviations

Applications
EIA, ICC, WB

Species Reactivity
H

Isotype
IgG1

Purification
Thiophilic adsorption and size exclusion chromatography

Immunogen
C-terminal peptide conjugated to KLH; C-Terminus of Amyloid beta A4 (1-42), does not cross react with beta A4 (1-40)

Host
Mouse

Clone Number
8G7

For research use only, not for diagnostic or therapeutic use.

Documentation
Spec Sheet

Ordering Info
Click here to learn more about online ordering
Order by phone: 734-668-6113 or 877-423-4548
Order by e-mail: orders@assaydesigns.com
Order by fax: 734-669-0134